The molecular imaging laboratory offers a wide array of quantitative measurements in live animals.
PET and SPECT systems are serving femtomolar sensitivity isotope-based methods. The very high sensitivity of PET and SPECT are complemented by anatomic measurements of MRI and CT. Protein expression and organ-specific fluorescence are measured deep in intact tissues using our unique Short-wave infrared fluorescence system. Stroke-related blood flow changes in turn, are quantified with a ultra-resolution ultrasound device. Radiochemical and nanoparticle laboratories are integrated to the whole animal imaging workflow. We can serve the needs of cardiology translational research groups from synthesis to radiomics-based image data analysis.
Our hardware is complementing a very experienced team with a decade of international collaborations.
Mediso nanoScan® PET/MRI 3T: Full-scale, quantitative PET combined with a robust, cryogen-free 3 Tesla MRI, resolution of PET 0.3 mm, MR resolution 50 microns.
Mediso nanoScan® SPECT/CT: absolute quantification and full stationary dynamic ECG-gated imaging down to 0.3 mm in vivo resolution of SPECT and 10 microns of CT.
Mediso nanoScan® 1T MRI: High soft tissue contrast, cost-effective solution. The compact system with high-performance magnet is optimized to perform fast (seconds to minutes) routine studies with high resolution (100 microns) of soft tissue contrast.
Iconeus One: This is the first and only fully-featured acquisition system for pre-clinical brain activity and vasculature functional ultrasound (fUS). 15 MHz and 3 micron resolution.
IR VIVO™ – NIR-II: Preclinical Imager is an infrared multispectral system for small animal studies, unique in Europe offering real tissue penetration infrared fluorescent images in the whole mouse depth.
FOBITM fluorescence system: for an affordable and very reliable full range visible fluorescent imaging result.
Software
Mediso Fusion full suite of image analysis and image co-registration. GeoFract software of geometric parameter and fractal analysis on images. We also have access to OLINDA radioactive dosimetry software.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 739593. HCEMM supported by EU Programme: H2020-EU.4.a. – Teaming of excellent research institutions and low performing RDI regions. Project starting date was 1 April 2017.